Anthem Blue Cross Blue Shield of Colorado prior authorization, page 45

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
81560Transplantation medicine (allograft rejection, pediatric liver and small bowel), measurement of donor and third-party-induced CD154+T-cytotoxic memory cells, utilizing whole pColorado Prior Authorization List, Pg 107 Original policy
81595Cardiology (heart transplant), mRNA, gene expression profiling by real-time quantitative PCR of 20 genes (11 content and 9 housekeeping), utilizing subfraction of peripheral bColorado Prior Authorization List, Pg 107 Original policy
81596Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizColorado Prior Authorization List, Pg 107 Original policy
82233Beta-amyloid; 1-40Colorado Prior Authorization List, Pg 107 Original policy
82234Beta-amyloid; 1-42Colorado Prior Authorization List, Pg 107 Original policy
82542Column Chromatography/Mass Spectrometry; Quantitative, Single Stationary & Mobile PhaseColorado Prior Authorization List, Pg 107 Original policy
82787Gammaglobulin (immunoglobulin); immunoglobulin subclasses (eg, IgG1, 2, 3, or 4), eachColorado Prior Authorization List, Pg 107 Original policy
83516Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitativColorado Prior Authorization List, Pg 107 Original policy
83520Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise spColorado Prior Authorization List, Pg 107 Original policy
83884Neurofilament light chainColorado Prior Authorization List, Pg 107 Original policy
83921Organic Acid, Single, QuantitativeColorado Prior Authorization List, Pg 107 Original policy
84393Tau, phosphorylatedColorado Prior Authorization List, Pg 107 Original policy
84394Tau, totalColorado Prior Authorization List, Pg 107 Original policy
86001Allergen Specific Igg Quantitative/Semiquantitative, Ea AllergenColorado Prior Authorization List, Pg 107 Original policy
86152Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood)Colorado Prior Authorization List, Pg 107 Original policy
86153Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood); physician interpretation and report, when requiredColorado Prior Authorization List, Pg 107 Original policy
86343Leukocyte Histamine Release Test (Lhr)Colorado Prior Authorization List, Pg 107 Original policy
86352Cellular function assay involving stimulation (eg, mitogen or antigen) and detection of biomarker (eg, ATP)Colorado Prior Authorization List, Pg 107 Original policy
86357Natural killer (NK) cells, total countColorado Prior Authorization List, Pg 107 Original policy
88356Morphometric Analysis; NerveColorado Prior Authorization List, Pg 108 Original policy
89329Sperm Evaluation; Hamster Penetration TestColorado Prior Authorization List, Pg 108 Original policy
89330Sperm Evaluation; Cervical Mucus Penetration Test, W/Wo Spinnbarkeit TestColorado Prior Authorization List, Pg 108 Original policy
90281Immune Globulin (Ig), Human, Im UseColorado Prior Authorization List, Pg 108 Original policy
90283Immune Globulin (Igiv), Human, Iv UseColorado Prior Authorization List, Pg 108 Original policy
90284Immune globulin (SCIg), human, for use in subcutaneous infusions, 100mg, eachColorado Prior Authorization List, Pg 108 Original policy
90378Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, eachColorado Prior Authorization List, Pg 108 Original policy
90380Respiratory syncytial virus, monoclonal antibody, seasonal dose; 0.5 mL dosage, for intramuscular useColorado Prior Authorization List, Pg 108 Original policy
90381Respiratory syncytial virus, monoclonal antibody, seasonal dose; 1 mL dosage, for intramuscular useColorado Prior Authorization List, Pg 108 Original policy
90382Respiratory syncytial virus, monoclonal antibody, seasonal dose, 0.7 mL, for intramuscular useColorado Prior Authorization List, Pg 108 Original policy
90867Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment; initial, including cortical mapping, motor threshold determination, delivery and managementColorado Prior Authorization List, Pg 108 Original policy
90868Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment; subsequent delivery and management, per sessionColorado Prior Authorization List, Pg 108 Original policy
90869Therapeutic Repetitive Transcranial Magnetic Stimulation (Tms) Treatment; Subsequent Motor Threshold Re-Determination With Delivery And ManagementColorado Prior Authorization List, Pg 108 Original policy
90875Individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy (eg, insight oriented, behavior mColorado Prior Authorization List, Pg 108 Original policy
90876Individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy (eg, insight oriented, behavior mColorado Prior Authorization List, Pg 108 Original policy
90901Biofeedback Training, Any ModalityColorado Prior Authorization List, Pg 108 Original policy
90912Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; initial 15 minutes of one-on-one physician or other quColorado Prior Authorization List, Pg 108 Original policy
90913Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; each additional 15 minutes of one-on- one physician orColorado Prior Authorization List, Pg 108 Original policy
91112Gastrointestinal transit and pressure measurement, stomach through colon, wireless capsule, with interpretation and reportColorado Prior Authorization List, Pg 108 Original policy
92507Treatment of speech, language, voice, communication, and/or auditory processing disorder; individualColorado Prior Authorization List, Pg 108 Original policy
92508Treatment of speech, language, voice, communication, and/or auditory processing disorder; group, 2 or more individualsColorado Prior Authorization List, Pg 108 Original policy
92521Evaluation of speech fluency (eg, stuttering, cluttering)Colorado Prior Authorization List, Pg 108 Original policy
92522Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria)Colorado Prior Authorization List, Pg 108 Original policy
92523Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive anColorado Prior Authorization List, Pg 109 Original policy
92524Behavioral and qualitative analysis of voice and resonanceColorado Prior Authorization List, Pg 109 Original policy
92526Treatment, Swallowing Dysfunction &/Or Oral Function, FeedingColorado Prior Authorization List, Pg 109 Original policy
92605Evaluation for prescription of non-speech-generating augmentative and alternative communication device, face-to-face with the patient; first hourColorado Prior Authorization List, Pg 109 Original policy
92606Therapeutic Service(S), Use Non-Speech Generatiing Device, W/Programming & ModificationColorado Prior Authorization List, Pg 109 Original policy
92607Eval, Prescription, Speech-Generating Augmentative & Alternative Communication Device; 1st HrColorado Prior Authorization List, Pg 109 Original policy
92608Eval, Prescrip, Speech-Generating Augmentative & Alternative Communication Device; Ea Add'l 30 MinColorado Prior Authorization List, Pg 109 Original policy
92609Therapeutic Services, Non-Speech Generative Device Use, W/Programming & ModificationColorado Prior Authorization List, Pg 109 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.